Therapeutics for diabetic complications
US6218411A · kind A · utility
14Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 8, 2000 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Feb 8, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent for treating or ameliorating diabetic complications which contains at least one potassium channel activator as an active ingredient. The drug is expected to show a therapeutic or ameliorating action on diabetic complications such as retinopathy, neuropathy, nephropathy, peripheral circulation disorders, and skin ulcerations; it also proves effective in preventing, ameliorating, alleviating and gaining recovery from various symptoms and abnormalities caused by those diseases, as exemplified by blindness, proteinurea, pain, numbness, psychroesthesia, intermittent claudication and gangrene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.